Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress
Main Content

Abstract Submissions

Abstract submissions are now closed. 

The deadline to submit original abstracts for presentation was March 15, 2022. Selected applicants will be notified in early June, 2022.

 

 

July 15, 2022  
Deadline to withdraw an accepted abstract 

July 31, 2022  
Deadline to submit  presentation materials  

Presenter Registration

MDS has reserved registrations for accepted abstract presenters. One presenter from each accepted abstract will be provided a code to register and present in person. Notifications and additional information will be emailed in the first week of June. Please note that this is not a complimentary registration; applicable registration fees will apply.

 

Abstract Presentations

The 2022 International Congress will take place in Madrid, Spain, and will also have a virtual platform. There will be a virtual poster hall in addition to in-person e-poster presentations for all presenters that attend in Madrid.

Abstract presenters have several options and can choose any or all of the following presentation formats. To provide the best user experience possible, all accepted abstract presenters are encouraged to participate in any/all virtual and in-person presentation options:

  1. Present as an e-poster in Madrid during scheduled poster sessions
    • High-ranking abstracts may also be selected for additional oral platform presentation
  2. Present as a pre-recorded video (oral) presentation on the MDS Congress virtual platform
  3. Present as an e-poster on the MDS Congress virtual platform

The designated abstract contact person must provide the final presentation choice for an individual abstract by July 31, 2022. If a selection is not received by the deadline, then the submission will only be presented as a full-text version of the abstract on the MDS Congress virtual platform, and will be published.

MDS strongly encourages all abstract presenters to participate in all presentation formats. Accepted abstract presenters should plan to attend the Congress to present the poster during the scheduled poster session(s). Attendance is not mandatory, and does not affect abstract acceptance or publication.
 

E-Poster Information

Additional details will be provided in the acceptance notification.

  • Format: Only PDF files will be accepted.
  • Number of pages: PDF poster must be kept to 1 page per abstract.
  • File size: 150 MB maximum file size.
  • Content: PDF poster must include the corresponding abstract as accepted, without changes.
  • Please ensure poster content is scientific in nature and refrain from including marketing or promotional materials.

Video Presentation

Additional details will be provided in the acceptance notification.

  • Duration: Your presentation should be no longer than five (5) minutes.
  • File type: If you upload your recording manually, it must be in MP4, H.264 format.
  • File size: The maximum file upload size allowed is 60 megabytes.
  • You will also have the option to record your video via the acceptance system.

Guidelines

Open AllClose All
Abstract Submission Guidelines

The abstract submission deadline was March 15, 2022, 11:59PM CST.
An individual may be the first author on a maximum of three (3) abstracts.
An individual may be a contributing author on an unlimited number of abstracts.
All submitted abstracts become the property of MDS.

Format

Text limit of 2,500 characters (including spaces). The size limit includes characters and spaces in the Abstract Title and Abstract Body. Please note that spaces are included in the overall character count. The size limit does not include author information.

Abstracts should be arranged as follows:

  • Objective
  • Background
  • Methods
  • Results
  • Conclusions
    *You may submit a case report using the standard abstract format

Do not include any identifying information directly on the abstract.

Only non-proprietary (generic) drug names should be used and should be written without capitals.

Do not include branded product names in the abstract. If the abstract is found to contain marketing, rather than scientific content, the abstract will be rejected.

Select one (1) category under which the abstract should be reviewed. If the abstract covers more than one topic, please choose the most appropriate category and indicate additional related topics via corresponding keywords. This will aid online searches and further organization of your abstract within the listed category (see “Review and Categorization” regarding re-categorizing a submitted abstract).

The use of standard abbreviations is desirable. A special or unusual abbreviation should be placed in parentheses after the first appearance of the full word for which it stands.

Please note there is a separate upload field for tables and graphs. To include tables or figures, enter the appropriate ID tag within the abstract body where the tables and/or figures should appear. Tags must be entered as shown - [table1] for your first table; [table2] for your second table; [figure1] for your first figure; [figure2] for your second figure.

To list references, enter the appropriate ID tag. [1] for your first reference, [2] for your second reference, [3] for your third reference, etc.

 

Submission and Eligibility

Abstract submissions are now closed.
The sole means of submission is via the Internet. Please do not e-mail, fax, or mail abstract submissions.


Abstracts must be submitted and presented in English.
MDS members and non-members are eligible to submit abstracts.
There is no fee for submitting an MDS abstract.
MDS does not offer CME credit for poster viewing or submitted abstracts.
MDS International Congress faculty are not required to submit an abstract.


All accepted abstracts will be published and included on the Congress virtual platform, regardless of in-person attendance status at the 2022 International Congress in Madrid. However, MDS strongly recommends attending in-person for the exceptional networking and collaboration opportunities. If accepted, all abstract presenters are responsible for their own registration and other fees associated with attending the International Congress.

 

Previously Published Abstracts and Plagiarism

All submitted abstracts will be run through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected.

Abstracts that have been presented at other meetings may be submitted if they have not been previously published. Submitted abstracts that have been presented at other meetings must include the previous meeting name and presentation date cited accordingly in the abstract body, after the Conclusion.

If the abstract is found to have been previously published in another MDS publication or a previous edition of the Movement Disorders journal, the designated contact person will be notified and required to revise the abstract, or the abstract will be rejected.

All abstracts presented at a previous MDS International Congress have been published by MDS.

MDS does not republish previously published International Congress abstracts.

 

Review and Categorization

The MDS Congress Scientific Program Committee will review all abstracts in March of 2022. The Committee shall be directed to reject abstracts for the following reasons:

  • Plagiarism detected
  • Marketing detected
  • Subject not related to the field of Movement Disorders
  • Does not meet basic requirements

All submitted abstracts will be run through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected.

If it is determined by the Congress Scientific Program Committee that a submitted abstract is not entered in the optimal abstract category listing, MDS reserves the right to re-categorize the abstract on behalf of the author(s) without prior notification. The new category placement will be confirmed in the official abstract notification letter.

If it is determined that the abstract should be re-categorized, MDS will ensure that the new category placement is in the best interest of the work and easily searchable by International Congress attendees as well as online researchers.

 

Notification and Correspondence

All notifications regarding a saved or submitted abstract will be sent only to the person identified as ‘Contact for Official Abstract Correspondence’. It is expected that the designated contact person will circulate updates regarding the abstract as needed.

All successfully submitted abstracts will receive a confirmation e-mail to the designated contact person. If the confirmation e-mail has not been received within 24-hours of submitting the abstract, please log in to the abstract submission site to verify the status of the submission.

Abstract acceptance notifications will be sent to the designated contact person via e-mail in June 2022. An official abstract notification letter will be available through the submission site and can be downloaded and printed at any time after notifications have been sent in June 2022.

All confirmed abstract submissions will be reviewed for acceptance by MDS.

Abstracts with a status of ‘saved’ are not confirmed submissions and will not be reviewed by MDS.

Please ensure that Omnipress is designated as a “safe sender” to ensure timely correspondence regarding the abstract submission.

Please check your spam and junk e-mail folders before contacting MDS regarding the status of your abstract. Abstract notices will come from Omnipress. Abstract status can also be checked directly on the submission site in June 2022.

 

Withdrawing a Submitted Abstract

March 15 – July 15, 2022
Requests to withdraw a submitted abstract after the submission deadline (March 15, 2022) must be received in writing by July 15, 2022 to congress@movementdisorders.org.

July 16, 2022 – Onward
After July 16, 2022, your abstract cannot be withdrawn and will remain a part of the 2022 MDS published abstracts. All submitted abstracts become the property of MDS.

 

Publication of Accepted Abstracts

All accepted abstracts will be published in an electronic supplement to the Movement Disorders journal online edition. All submitted abstracts become the property of MDS.

MDS only accepts original work. By submitting your abstract, you affirm that your abstract is your own, either individually or as a group. Should plagiarism be detected, the abstract will be rejected.

IMPORTANT: Abstract data and content can NOT be updated after it has been accepted (notifications will be sent in June 2022). Submissions must include all data as it will be published, without need for updating after submission. Please review all content prior to submitting; including author listing and spelling.

If the abstract data will not be available until after the submission deadline, then it is recommended to submit as a Late-Breaking Abstract (opening in June 2022).

 

Abstract Presentation

Abstract presenters have several options and can choose any or all of the following presentation formats. To provide the best user experience possible, all accepted abstract presenters are encouraged to participate in all virtual and in-person presentation options:

  1. Present an accepted abstract as an e-poster in Madrid during scheduled poster sessions
      - High-ranking abstracts may also be selected for additional oral platform presentation
  2. Present as a 5-minute pre-recorded video (oral) presentation on the MDS Congress virtual platform
  3. Present as an e-poster on the MDS Congress virtual platform

Poster specifications and details will be provided with the acceptance notification letter in June. Presenters that want to begin preparations can anticipate that e-posters will be a one-page PDF file not to exceed 150 MB in horizontal orientation (to best fit the monitor screen). Video presentations for the virtual platform must be in MP4 format, and not to excel 150 MB file size. Video presentation must not exceed 5 minutes duration. E-poster and video presentations will be collected in June 2022, after abstract acceptance notifications have been sent.

MDS strongly encourages all abstract presenters to participate in all presentation formats. Accepted abstract presenters should plan to attend the Congress to present the poster during the scheduled poster session(s). Attendance is not mandatory, and does not affect abstract acceptance or publication.

 

Support for Abstract Presenters

Travel Grant Awards 

MDS is offering up to 250 Travel Grant Awards to support delegates in financial need to attend International Congress.  

Applications have closed. 

Learn more »

Junior Awards 

Junior Award recipients selected for significant contribution to the field will present their abstract at the Presidential Lectures Plenary Session. 

Applications have closed.

Learn more »

 

2022 International Congress Abstract Publication

International Congress abstracts are published in Movement Disorders, the official Journal of the International Parkinson and Movement Disorders Society (MDS). 

Visit the searchable 2021 Virtual Congress Abstracts Website to view published abstracts or download the 2021 Abstracts PDF.

 

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice